Literature DB >> 1138697

Internuclear ophthalmoplegia of abduction. Isolated impairment of phasic ocular motor activity in supranuclear lesions.

G Kommerell.   

Abstract

Abduction saccadic movement slowed to either side without any limitation in the end position occurred in a patient. This ocular motor abnormality constituted a mirror image of the well-known internuclear ophthalmoplegia of abduction. Intermuclear ophthalmoplegia of either type demonstrates that a lesion between the center for conjugate gaze and the ocular motor nuclei can impair phasic activity of the eye muscles without reducing their tonic function.

Entities:  

Mesh：

Year:  1975        PMID： 1138697     DOI： 10.1001/archopht.1975.01010020547013

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


  5 in total

1.  Internuclear ophthalmoplegia of abduction: clinical and electrophysiological data on the existence of an abduction paresis of prenuclear origin.

Authors:  F Thömke; H C Hopf; G Krämer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

2.  A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer.

Authors:  J A Nij Bijvank; L J Balk; H S Tan; B M J Uitdehaag; L J van Rijn; A Petzold
Journal:  J Neurol       Date:  2017-02-13       Impact factor: 4.849

3.  [Internuclear ophthalmoplegia and associated oculomotor syndrome (author's transl)].

Authors:  M Caderas; M Meyer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

4.  Paresis of lateral gaze alternating with so-called posterior internuclear ophthalmoplegia. A partial paramedian pontine reticular formation-abducens nucleus syndrome.

Authors:  J Bogousslavsky; F Regli; B Ostinelli; T Rabinowicz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Abduction paresis with rostral pontine and/or mesencephalic lesions: Pseudoabducens palsy and its relation to the so-called posterior internuclear ophthalmoplegia of Lutz.

Authors:  F Thömke; H C Hopf
Journal:  BMC Neurol       Date:  2001-12-18       Impact factor: 2.474
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.